053sek
2,3 %
Date:2025-06-26Time:16:51:49Latest report:Q1-2025List:First NorthTicker:IDLDX
Market Cap:121 msekEnterprise Value:75 msekNet Sales:59,9 msekEarnings:-44,3 msekEmployees:0ISIN:SE0003883990

Ratios

10-year key figure history for IDL Diagnostics turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for IDL Diagnostics with index and moving average MA50 and MA200.

Stockprice:0,53
MA50:0,56
MA200:0,52
Price/MA200:1,6 %
RSI (14):47,0
Price/MA50:-5,9 %

Description

IDL Diagnostics specializes in oncology and bacteriology. The company has a broad product portfolio, and develops, markets and sells blood and urine sample tests that are used by hospitals and clinics. The tests are intended to provide information for the detection of diseases such as urological cancers and typhoid fever. IDL Diagnostics targets patient groups in different parts of the world. The head office is in Stockholm.

Biotechnology